Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 17,24117,260 of 20,252 grants

Completed SBIR-STTR RPGS
A multitargeted nanocarrier inhibitor of undruggable transcription factors for treating castration resistant prostate cancer
NATIONAL CANCER INSTITUTE Parabon Nanolabs, Inc United States 2021 – 2022

Project Summary This project addresses the critical need for treatments of castration resistant prostate cancer (CRPC) by proposing to engineer and develop a novel, nanostructured...

$2.51M
USD
Completed NON-SBIR/STTR RPGS
Control of regulatory T cells by IL-17 in colorectal cancer
NATIONAL CANCER INSTITUTE University of Connecticut Sch of Med/Dnt United States 2021 – 2026

Project Summary/Abstract: IL-17 family cytokines promote inflammation that drives the development of colorectal neoplasia, which eventually lead to colorectal cancer (CRC). Thus fa...

$3.75M
USD
Completed NON-SBIR/STTR RPGS
Prostate Cancer Vulnerabilities to BH3 Mimetic Drugs
NATIONAL CANCER INSTITUTE Beth Israel Deaconess Medical Center United States 2021 – 2026

The anti-apoptotic BCL2 family proteins (including BCL2, BCLXL, and MCL1) act by neutralizing BAX and BAK, and by inhibiting the BH3-only pro-apoptotic proteins that can activate B...

$4M
USD
Completed NON-SBIR/STTR RPGS
Novel Strategies to Treat Diffuse Midline Glioma with CAR T Cell Therapy
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2021 – 2023

PROJECT SUMMARY Although chimeric antigen receptor (CAR) T cells have been remarkably successful in the hematologic setting, identification of truly tumor specific antigens for man...

$2.23M
USD
Completed NON-SBIR/STTR RPGS
Hyperthermic Intraperitoneal Chemotherapy Mechanisms in Epithelial Ovarian Cancer
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2021 – 2023

Project Summary Epithelial ovarian cancer (EOC) is a leading cause of gynecologic cancer death in women, highlighting the critical clinical need for new therapeutic strategies.In 2...

$2.26M
USD
Completed NON-SBIR/STTR RPGS
Modulating extracellular TCR-CD3 interactions to identify new melanoma immunotherapy targets
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2021 – 2023

ABSTRACT Melanoma is one of the deadliest and aggressive form of skin cancer.Main treatment options in metastatic melanoma involve T cell immunotherapy using checkpoint blockade (a...

$2.38M
USD
Completed NON-SBIR/STTR RPGS
Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Five-year survival rate of pancreatic ductal adenocarcinoma (PDAC) still remains at a dismal 10%.This poor outcome is attributed to PDAC?s complex tumor mi...

$4.48M
USD
Completed NON-SBIR/STTR RPGS
Modulation of Mcl-1 for Treatment of Lung Cancer
NATIONAL CANCER INSTITUTE Emory University United States 2021 – 2026

Summary KRAS mutations activate Raf/MEK/ERK1/2 that can directly phosphorylate Mcl-1 at T163, enhancing Mcl-1?s function.KRAS mutations also activate PI3K/AKT that can inactivate G...

$4.33M
USD
Completed NON-SBIR/STTR RPGS
OPTIMISE: A Shared Care Approach for Improving Comprehensive Care of Cancer Patients with Comorbidities in A Safety-Net System
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2026

PROJECT SUMMARY.Cancer survivors have unique healthcare needs including risk for serious late effects, ongoing surveillance, lifestyle modifications to reduce second cancer risk, a...

$6.58M
USD
Completed NON-SBIR/STTR RPGS
The Impact of Cigarillo Warnings on Purchasing and Smoking Behaviors Among Young Adult Cigarillo Users
NATIONAL CANCER INSTITUTE Wake Forest University Health Sciences United States 2021 – 2024

Project Summary Cigarillo use remains a public health concern, particularly among vulnerable populations. Young adults, including those who are Black or African American, have the...

$4.06M
USD
Completed NON-SBIR/STTR RPGS
Novel Perceptual and Oculomotor Heuristics for Enhancing Radiologic Performance
NATIONAL CANCER INSTITUTE Suny Downstate Medical Center United States 2021 – 2026

PROGRAM SUMMARY Radiological imaging is often the first step of the diagnostic pathway for many devastating diseases; thus, an erroneous assessment of ?normal? can lead to death.Wh...

$6.46M
USD
Active NON-SBIR/STTR RPGS
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2021 – 2027

ABSTRACT Immune checkpoint inhibitors (ICIs) are a powerful and innovative mode of cancer therapy, believed to be partially responsible for the largest single-year drop in cancer m...

$10.6M
USD
Completed TRAINING, INDIVIDUAL
Role of a Two-Factor Genetic Circuit Regulating Stemness in Colorectal Cancer
NATIONAL CANCER INSTITUTE Harvard Medical School United States 2021 – 2025

Project Summary Colorectal cancer (CRC) is the third leading cause of cancer death worldwide.Cancer stem cells (CSCs) in the colon are the source of tumor initiation, proliferation...

$510.4K
USD
Completed TRAINING, INDIVIDUAL
Molecular and cancer-related roles of ACLY exon 14
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2025

Project Summary The goal of this proposal is to understand the molecular role of alternative splicing and phosphorylation of ATP- citrate lyase (ACLY) exon 14 and how these events...

$460.4K
USD
Completed NON-SBIR/STTR RPGS
Lentiviral-Induced Swine Model of Spinal Cord Glioma
NATIONAL CANCER INSTITUTE Emory University United States 2021 – 2026

PROJECT SUMMARY High-grade Spinal Cord Glioma (SCG) is an orphan disease that results in significant morbidity and mortality, with no effective treatment options available.Despite...

$5.42M
USD
Completed TRAINING, INDIVIDUAL
The Interplay Between PD-1 Blockade and T cell Development in the Context of Thymic Regeneration in Prostate Cancer
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2023

PROJECT SUMMARY Immunotherapies, such as PD-1 blockade, have shown therapeutic potential in prostate cancer; however, only a portion of patients respond, suggesting unidentified me...

$460.4K
USD
Completed TRAINING, INDIVIDUAL
Defining protein synthesis demands and specificities in multiple myeloma
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2024

PROJECT SUMMARY Multiple Myeloma (MM) is an incurable cancer of differentiated B lymphocytes (or ?plasma cells?) which generally presents late in life and has a median life expecta...

$510.4K
USD
Completed TRAINING, INDIVIDUAL
Elucidating the Role of Epigenetic Plasticity in anti-GD2 Immunotherapy Response
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2024

Project Summary Ganglioside GD2 is expressed on the cell surface of numerous pediatric cancers, including Ewing sarcoma, osteosarcoma, and neuroblastoma.In 2015, FDA approval of th...

$656.1K
USD
Completed NON-SBIR/STTR RPGS
Novel Mechanistic Approaches in Prevention, Treatment and Non-Invasive Assessment of Radiation Cystitis in Mice
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2025

ABSTRACT Pelvic organ tumors in men and women are projected to account for 40% and 18%, respectively, of new cancers diagnosed, and 31% and 26%, respectively, of cancer related dea...

$4.43M
USD
Completed NON-SBIR/STTR RPGS
Analysis and Therapeutic Targeting of the Linear-Ubiquitination Pathway in Hodgkin Lymphoma
NATIONAL CANCER INSTITUTE Research Inst of Fox Chase Can Ctr United States 2021 – 2026

PROJECT SUMMARY Hodgkin lymphoma (HL) is the most common (6,000 to 7,000 new cases per year) lymphoma subtype in young adulthood.Although there has been great progress during the l...

$4.28M
USD